Clinical Trials Directory

Trials / Unknown

UnknownNCT03553342

Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Thyroidectomy is a common surgical procedure in France. Recurrent paralysis is one of the main complications. Oral corticosteroid therapy are frequently used at a dosage of 1mg/kg for seven days, in case of recurrent paralysis to obtain remobilization as early as possible. The main objective is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy.

Conditions

Interventions

TypeNameDescription
DRUGCorticoidsPatients will receive corticosteroids therapy: 1mg/kg of prednisolone daily for seven days.
OTHERPlaceboPatients will receive placebo for seven days.

Timeline

Start date
2018-09-11
Primary completion
2021-09-11
Completion
2022-01-11
First posted
2018-06-12
Last updated
2021-01-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03553342. Inclusion in this directory is not an endorsement.